Experts say that surgical robots or robot doctors will be conducting one in three operations in the US in the next five years. The surgical robots are estimated to multiply two folds by 2021, with surgeons guiding mechanical them on comp…
BMI View: Growth in Lebanon's pharmaceutical market will be heavily driven by the sales of high-value
prescription medicines thanks to an aging population, relatively high per capita spending and rising disease
burden. Furthermore, the Health Ministry's recent move to increase healthcare coverage for citizens over
the age of 64 highlights the country's commitment to improving healthcare quality and access across the
country. However, ongoing regional instability and Lebanon's own economic stagnation will continue to
dampen multinational drugmakers' interest in the market.
Headline Expenditure Projections
? Pharmaceuticals: LBP2.47trn (USD1.64bn) in 2015 to LBP2.60trn (USD1.72bn) in 2016; +5.5% in
local currency and US dollar terms. Forecast revised downwards slightly from last quarter.
? Healthcare: LBP5.04trn (USD3.34bn) in 2015 to LBP5.27trn (USD3.50bn) in 2016; +4.8% in local
currency and US dollar terms. Forecast unchanged from last quarter.